SCROLL
Xeureka Inc. uses the latest computational technology,
including cutting-edge AI and simulations,
to improve the efficiency and success rate of drug discovery research.
Ultimately, we aim to contribute to the swift,
economical delivery of effective medicines to patients suffering from disease.
In addition to analysis and screening services, we plan to sell software and provide SaaS in the future.
Please contact us to discuss how we can customize a solution to meet your needs, including the establishment of a computing environment.
READ MORE
READ MORE
READ MORE
2025.10 17
NEWS
Sponsored Session at the CBI Annual Meeting 2025: GPU × AI-Powered Drug Discovery R&D — Sharing Knowledge and Growing the Tokyo-1 CommunityREAD MORE
2025.10 03
BLOG
Tokyo-1 Drug Discovery Hackathon 2025 Event ReportREAD MORE
2025.04 23
NEWS
Xeureka begins AI drug discovery research support on constrained peptides with FunPepREAD MORE